Cipla Launches India’s First Inhalable Insulin, Afrezza
RNS: Cipla has introduced Afrezza, India’s first inhalable insulin, following approval from the Central Drugs Standard Control Organisation (CDSCO). Developed …
Cipla Launches India’s First Inhalable Insulin, Afrezza Read More